Virginia House Bill HB1787

Virginia 2023 Regular Session

• Introduced: 1/10/23
• Refer: 1/10/23

Caption

Schedule VI controlled substance; practitioner-patient relationship.

Impact

The proposed bill could significantly impact state laws concerning how healthcare providers interact with patients and how medications, especially controlled substances, are prescribed and dispensed. By requiring a bona fide relationship, the legislation attempts to confirm that prescriptions are made for legitimate medical purposes only. Moreover, the allowance for telemedicine under certain conditions can facilitate access to healthcare, particularly for patients who may not be able to meet in person due to distance or other barriers. This could lead to broader access to necessary medications, potentially reducing the burden on hospitals and in-person care facilities.

Summary

House Bill 1787 aims to regulate the prescription and dispensing of Schedule VI controlled substances, focusing on the requirements for establishing a bona fide practitioner-patient-pharmacist relationship. The bill underscores the necessity for practitioners to ensure that prescriptions are issued only under circumstances where a valid relationship exists, aimed at preventing misuse and ensuring that medications are prescribed responsibly. Furthermore, the legislation includes provisions for utilizing telemedicine to facilitate these prescriptions, thereby modernizing healthcare delivery in the state.

Contention

Notably, there may be challenges to the implementation of HB1787, particularly concerning the verification process of the practitioner-patient relationship when using telemedicine. Critics may argue that while telemedicine expands access, it could also risk oversights in patient evaluation, particularly if a personal examination is not mandated by the standard of care. Additionally, there may be concerns about the adequacy of oversight on prescriptions issued via telemedicine, which could potentially lead to prescription abuse if not handled carefully. Thus, the legislation might ignite debates around balancing access to health care with safeguarding against potential prescription misuse.